Zai Lab: Revenue Growth And Zoci's Upside Optionality (NASDAQ:ZLAB)
· seekingalpha.com
Zai Lab has grown from a Greater China licensing platform into a dual-engine biopharma. Click here to find out why ZLAB stock is a Buy.
Zai Lab Limited ( ZLAB ) is a biopharma based in the US and China. They have a growing presence in oncology, immunology, and other specialty therapeutic areas. ...